Clinical Trial Update: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of gemcitabine and topotecan for refractory or recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Topotecan (topotecan)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: TERMINATED